10 March 2026 - Top Stories

Australia’s healthtech signal is the move to scalable, value‑based care underpinned by HealthPathways and data‑driven governance for AI in health.

The push for collaborative commissioning between Local Hospital Networks and Primary Health Networks—backed by an estimated $600 million annual saving potential and deliberate reductions in preventable hospitalisations (about 5%) and emergency visits (around 4%)—creates a new standard for interoperable care pathways. The practical challenge is rollout across regions, which makes HealthPathways a critical infrastructure play for vendors, systems integrators and public sector buyers aiming to standardise care design, procurement and evaluation.

Enhancements to My Health Record are accelerating care coordination, with faster access to imaging and diagnostic results and a five‑day viewing window for key tests. For executives, the implication is a stronger case for interoperable EHRs and patient portals, but it also raises safety, governance and workflow questions that will shape adoption and vendor risk management.

A governance‑led AI trajectory is emerging, anchored by partnerships like Svitla Systems and Cloudera that promise trusted data foundations for secure, production‑ready analytics in healthcare. The block appears to be data readiness: fragmented, poorly governed data across cloud, on‑premise and legacy systems remains the core obstacle to scaling AI. The industry will rely on mature data ecosystems and regulatory alignment to turn pilots into enduring value.

Victoria’s Chemist Care Now move to pharmacist prescribing—with free consultations and a broader list of treatments planned—tests how primary care access can shift with pharmacy‑led tooling and safety workflows. This will pressure pharmacy‑software ecosystems and digital prescribing controls, while potentially easing GP workloads if safety and oversight keep pace with demand.

Policy gaps around ME/CFS and long‑covid care risk stalling digital health gains unless funding, specialist centres and paediatric services materialise. Without tangible care pathways and data collection, digital tooling may fail to close care gaps amid a rising patient burden.

• HealthPathways and collaborative commissioning set a standard for value‑based care, driving demand for interoperable health IT platforms and procurement capabilities, so executives should prioritise integration readiness.
• My Health Record's faster imaging and pathology viewing accelerates care coordination, creating urgency for real‑time interoperability while requiring robust safety and workflow safeguards.
• AI governance‑first data foundations, as evidenced by the Svitla‑Cloudera alliance, are becoming crucial to scale AI in regulated health settings, so leaders must invest in data maturity and cross‑system governance.
• Victoria’s pharmacist prescribing experiment signals a broader shift in primary care delivery, demanding updated pharmacy software, safety checks and workflow automation to realise workload relief without compromising safety.
• ME/CFS and long‑covid policy execution gaps threaten to blunt digital health investments, so executives should push for concrete clinics, funding and data standards to unlock digital care improvements.
• The move to digital claiming and the retirement of paper rebates will require real‑time revenue cycles and EFT workflow enhancements across GP software ecosystems, making readiness for digital claims a core IT priority.
• There is a clear opportunity to address women’s health equity with gender‑informed data and decision support, enabling primary care tooling to close non‑reproductive care gaps and improve outcomes.